Pulse: Industry Perspectives

Communicate, motivate and activate for successful patient recruitment

Monday, June 19, 2017

The Pulse on Patient Recruitment by Ashley Tointon

Recruiting patients for clinical trials is not as straightforward as it may seem. Identify­ing patients that match the inclusion and exclusion criteria can be an immense task on its own, yet it is not simply the identification that leads to successful enrollment. In order to collect optimal data, it is imperative to communicate, motivate and activate those patients who are willing to invest their time as participants.

[Read More]

Publication bias and clinical trial outcomes reporting

Monday, June 12, 2017

The Pulse on Global Trials by Matthew Howes

Last month, the world’s leading funders of medical research and international non-governmental organizations agreed to set forth new standards that will require all clinical trials they fund or support to be registered, and the results disclosed publicly within mandatory timeframes. The aim is to dramatically improve both the quality of therapies available to patients, as well as the quality of research that leads to new breakthrough. But the question remains: Will it be enough?

[Read More]

Alternative solutions to complement monitoring strategies

Monday, June 5, 2017

The Pulse on Site Success by Christophe Berthoux

Research sites are likely most familiar with traditional on-site monitoring, which requires monitors to conduct visits to check a high percentage of data, and ensure that everything is reported correctly. As clinical trials increase in complexity, on-site monitoring can become an inefficient and expensive process. In order to minimize cost and increase efficiency, Sponsors and CROs are considering several alternative solutions to complement monitoring strategies.

[Read More]

Coordinating effective contingency training plans

Tuesday, May 30, 2017

The Pulse on Study Conduct by Elizabeth Weeks-Rowe

The call to participate in clinical research is transforming for patients, practitioners and research staff. Effectively executed drug studies can result in life changing therapies that level the playing field of human illness.

[Read More]

All for one and one for all: A call for a Three Musketeers approach to online profiles

Monday, May 22, 2017

The Pulse on Technology by Elisa Cascade

We all know there is an issue surrounding investigator participation in industry-sponsored clinical trials. Tufts University puts the figure for doctors declining to return for a second study at approximately 40%. At the same time, the number of global clinical trials continues to rise and increase in complexity. We’ve all read articles and attended conferences that expound the passionate view that investigators who commit their time and expertise need our help and encouragement. But if that’s the case, why do we as an industry fail to address the administrative burdens driving them away?

[Read More]

The illusion of safety in study startup

Monday, May 15, 2017

The Pulse on Study Startup by Craig Morgan

Risk is our constant companion, and as clinical trials grow in complexity, so do risk-based challenges to bring new therapies to market at an ever-increasing pace. The continued reliance on Excel, which lacks project- and risk-management functionality, has created an illusion of safety often fueling the rescue study industry.

[Read More]

Best and worst digital campaigns for patient recruitment

Monday, May 8, 2017

The Pulse on Patient Recruitment by Ashley Tointon

Recently, I was asked to discuss aspects of my best and worst digital campaigns for patient recruitment. Having completed so many digital campaigns, it is difficult to discern the best and worst, as they all had different parameters. Looking back retrospectively, distinct markers of good digital planning were determined primarily by two factors—strategy and execution.

[Read More]

Patient advocacy in clinical research

Monday, May 1, 2017

The Pulse on Global Trials by Matthew Howes

Earlier this year, the FDA approved the first artificial pancreas for type 1 diabetes. The advancement is remarkable not just for the technology alone, but for how it came to be.

[Read More]

Social media tips for research sites

Monday, April 24, 2017

The Pulse on Site Success by Christophe Berthoux

When sites are juggling multiple studies, it can be easy to push social media efforts to the backseat. However, this may deter from opportunities to expand clinical trial awareness and potentially bringing new business to sites. Fortunately, a site can implement tools and processes to allow for social media interaction, while maintaining the balance between keeping up with administrative workloads and providing patient care.

[Read More]

Perfection’s role in a clinical researcher’s job performance

Monday, April 17, 2017

The Pulse on Study Conduct by Elizabeth Weeks-Rowe

The pursuit of, or expectation of, perfection in a clinical researcher’s job performance is a flawed ideology, rife with disappointment for anyone shouldering this impossible burden. As my father, R Stuart Weeks, M.D., used to say, “The pursuit of perfection prevents progress.”

[Read More]